Tower Research Capital (TRC)’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-896
| Closed | -$19.2K | – | 6200 |
|
|
2024
Q1 | $19.2K | Buy |
+896
| New | +$19.2K | ﹤0.01% | 3032 |
|
|
2023
Q4 | – | Sell |
-1,180
| Closed | -$4.58K | – | 6402 |
|
|
2023
Q3 | $4.58K | Sell |
1,180
-362
| -23% | -$1.4K | ﹤0.01% | 4844 |
|
|
2023
Q2 | $6.49K | Sell |
1,542
-584
| -27% | -$2.46K | ﹤0.01% | 4675 |
|
|
2023
Q1 | $6K | Buy |
2,126
+352
| +20% | +$993 | ﹤0.01% | 4918 |
|
|
2022
Q4 | $9K | Buy |
1,774
+772
| +77% | +$3.92K | ﹤0.01% | 4338 |
|
|
2022
Q3 | $7K | Buy |
1,002
+36
| +4% | +$251 | ﹤0.01% | 4968 |
|
|
2022
Q2 | $7K | Buy |
966
+369
| +62% | +$2.67K | ﹤0.01% | 4862 |
|
|
2022
Q1 | $9K | Buy |
597
+200
| +50% | +$3.02K | ﹤0.01% | 4526 |
|
|
2021
Q4 | $19K | Buy |
397
+332
| +511% | +$15.9K | ﹤0.01% | 3760 |
|
|
2021
Q3 | $10K | Sell |
65
-78
| -55% | -$12K | ﹤0.01% | 4374 |
|
|
2021
Q2 | $16K | Buy |
143
+42
| +42% | +$4.7K | ﹤0.01% | 4100 |
|
|
2021
Q1 | $10K | Buy |
+101
| New | +$10K | ﹤0.01% | 4393 |
|